Bollard Group LLC Abbott Laboratories Transaction History

Bollard Group LLC

  • $3.76 Billion
  • Q3 2024

A detailed history of Bollard Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bollard Group LLC holds 100,622 shares of ABT stock, worth $11.5 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
100,622
Previous 100,183 0.44%
Holding current value
$11.5 Million
Previous $10.4 Million 10.2%
% of portfolio
0.31%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$100.07 - $118.13 $43,930 - $51,859
439 Added 0.44%
100,622 $11.5 Million
Q2 2024

Aug 14, 2024
BUY
$100.73 - $112.44 $156,635 - $174,844
1,555 Added 1.58%
100,183 $10.4 Million
Q1 2024

May 13, 2024
BUY
$109.52 - $120.96 $78,525 - $86,728
717 Added 0.73%
98,628 $11.2 Million
Q4 2023

Feb 13, 2024
BUY
$90.19 - $110.4 $508,491 - $622,435
5,638 Added 6.11%
97,911 $10.8 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $976,221 - $1.17 Million
-10,219 Reduced 9.97%
92,273 $8.94 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $44,947 - $50,081
446 Added 0.44%
102,492 $11.2 Million
Q1 2023

May 12, 2023
BUY
$96.86 - $114.01 $33,901 - $39,903
350 Added 0.34%
102,046 $10.3 Million
Q4 2022

Feb 10, 2023
SELL
$95.06 - $111.52 $574,447 - $673,915
-6,043 Reduced 5.61%
101,696 $11.2 Million
Q3 2022

Nov 09, 2022
BUY
$96.76 - $112.03 $32,608 - $37,754
337 Added 0.31%
107,739 $10.4 Million
Q2 2022

Aug 12, 2022
BUY
$102.07 - $123.37 $44,094 - $53,295
432 Added 0.4%
107,402 $11.7 Million
Q1 2022

May 12, 2022
BUY
$114.02 - $139.04 $168,977 - $206,057
1,482 Added 1.4%
106,970 $12.7 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $62,270 - $76,246
539 Added 0.51%
105,488 $14.8 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $47,947 - $53,043
411 Added 0.39%
104,949 $12.4 Million
Q2 2021

Aug 12, 2021
BUY
$105.79 - $124.53 $40,729 - $47,944
385 Added 0.37%
104,538 $12.1 Million
Q1 2021

May 11, 2021
BUY
$108.84 - $128.23 $15,890 - $18,721
146 Added 0.14%
104,153 $12.5 Million
Q4 2020

Feb 04, 2021
SELL
$105.0 - $114.42 $1.68 Million - $1.83 Million
-16,019 Reduced 13.35%
104,007 $11.4 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $13,471 - $16,359
147 Added 0.12%
120,026 $13.1 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $3.71 Million - $4.74 Million
-48,392 Reduced 28.76%
119,879 $11 Million
Q1 2020

May 14, 2020
BUY
$62.82 - $91.86 $54,088 - $79,091
861 Added 0.51%
168,271 $13.3 Million
Q4 2019

Feb 10, 2020
BUY
$78.51 - $87.4 $31,796 - $35,397
405 Added 0.24%
167,410 $14.5 Million
Q3 2019

Nov 13, 2019
BUY
$81.84 - $88.74 $32,408 - $35,141
396 Added 0.24%
167,005 $14 Million
Q2 2019

Aug 13, 2019
BUY
$72.88 - $85.0 $671,516 - $783,190
9,214 Added 5.85%
166,609 $14 Million
Q1 2019

May 10, 2019
BUY
$66.22 - $80.06 $859,204 - $1.04 Million
12,975 Added 8.98%
157,395 $12.6 Million
Q4 2018

Feb 05, 2019
BUY
$65.56 - $74.27 $412,896 - $467,752
6,298 Added 4.56%
144,420 $10.4 Million
Q3 2018

Nov 08, 2018
BUY
$60.81 - $73.36 $334,698 - $403,773
5,504 Added 4.15%
138,122 $10.1 Million
Q2 2018

Aug 09, 2018
BUY
$57.57 - $63.54 $329,818 - $364,020
5,729 Added 4.51%
132,618 $8.09 Million
Q1 2018

May 14, 2018
BUY
$56.27 - $63.62 $362,097 - $409,394
6,435 Added 5.34%
126,889 $7.6 Million
Q4 2017

Jan 29, 2018
BUY
$53.68 - $57.47 $102,528 - $109,767
1,910 Added 1.61%
120,454 $6.87 Million
Q3 2017

Oct 27, 2017
BUY
$48.06 - $53.64 $5.7 Million - $6.36 Million
118,544
118,544 $6.33 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email